Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol

Doreen DeFaria Yeh1, Mason W Freeman, James B Meigs

  • 1Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. doreen.defaria@gmail.com

Insights

High high-density lipoprotein (HDL) levels in patients with coronary artery disease (CAD) are associated with a similar or lower prevalence of traditional CAD risk factors. This finding challenges the notion that high HDL necessitates a greater burden of other cardiovascular risks.

Area of Science:

  • Cardiology
  • Lipid Metabolism
  • Preventive Medicine

Background:

  • High high-density lipoprotein (HDL) levels are recognized for their protective role against coronary artery disease (CAD) development.
  • The relationship between elevated HDL cholesterol and the prevalence of other CAD risk factors in patients already diagnosed with CAD requires further elucidation.

Purpose of the Study:

  • To investigate the prevalence of traditional cardiovascular disease risk factors in patients with established CAD and high HDL levels.
  • To compare these risk factors against those in patients with CAD and normal HDL levels.

Main Methods:

  • Retrospective analysis of 41,982 patients, identifying a cohort of 1,610 patients with CAD.
  • Comparison of 98 patients with high HDL levels against 1,512 patients with normal HDL levels, matched for age, gender, and HDL levels.
  • Manual chart review for detailed analysis of family history and lifestyle factors.

Main Results:

  • Patients with CAD and high HDL levels exhibited similar age and hypertension prevalence compared to those with normal HDL.
  • Significantly lower levels of low-density lipoprotein (LDL) and triglycerides were observed in the high HDL group.
  • The high HDL group showed a lower prevalence of diabetes and obesity, confirmed by logistic regression analysis.

Conclusions:

  • In patients with coronary artery disease, high HDL levels are not associated with a greater prevalence of traditional risk factors.
  • Elevated HDL cholesterol in CAD patients may indicate a healthier metabolic profile, with lower risks of diabetes and obesity.
  • These findings suggest that high HDL may represent a marker of resilience rather than an indicator of increased overall cardiovascular risk burden in CAD patients.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...